Intuitive Surgical (NASDAQ:ISRG) was upgraded by stock analysts at BidaskClub from a “hold” rating to a “buy” rating in a research note issued on Tuesday, BidAskClub reports.

A number of other brokerages have also issued reports on ISRG. Zacks Investment Research lowered Intuitive Surgical from a “hold” rating to a “sell” rating in a research report on Thursday, April 11th. Cantor Fitzgerald set a $620.00 target price on Intuitive Surgical and gave the company a “buy” rating in a research report on Thursday, April 4th. Deutsche Bank began coverage on Intuitive Surgical in a research report on Monday, April 1st. They set a “buy” rating and a $630.00 target price on the stock. Raymond James increased their target price on Intuitive Surgical from $600.00 to $630.00 and gave the company an “outperform” rating in a research report on Monday, April 1st. Finally, Royal Bank of Canada set a $560.00 target price on Intuitive Surgical and gave the company a “hold” rating in a research report on Thursday, February 28th. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and fourteen have assigned a buy rating to the company’s stock. Intuitive Surgical currently has an average rating of “Buy” and an average price target of $576.82.

Shares of NASDAQ:ISRG opened at $501.92 on Tuesday. Intuitive Surgical has a 1 year low of $430.24 and a 1 year high of $589.32. The company has a market cap of $58.48 billion, a PE ratio of 52.89, a price-to-earnings-growth ratio of 4.42 and a beta of 1.06.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, April 18th. The medical equipment provider reported $2.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.70 by ($0.09). Intuitive Surgical had a net margin of 29.78% and a return on equity of 17.33%. The business had revenue of $974.00 million for the quarter, compared to analysts’ expectations of $975.27 million. During the same quarter last year, the business earned $2.44 EPS. The company’s quarterly revenue was up 14.9% on a year-over-year basis. As a group, analysts expect that Intuitive Surgical will post 9.4 earnings per share for the current fiscal year.

In other Intuitive Surgical news, VP Jamie Samath sold 260 shares of the firm’s stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $500.00, for a total value of $130,000.00. Following the transaction, the vice president now owns 278 shares in the company, valued at approximately $139,000. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Gary S. Guthart sold 22,636 shares of the firm’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $501.48, for a total value of $11,351,501.28. Following the completion of the transaction, the chief executive officer now owns 386,866 shares in the company, valued at approximately $194,005,561.68. The disclosure for this sale can be found here. Insiders sold a total of 27,621 shares of company stock worth $13,828,454 in the last 90 days. 1.70% of the stock is currently owned by insiders.

A number of hedge funds have recently made changes to their positions in the business. Oregon Public Employees Retirement Fund increased its stake in shares of Intuitive Surgical by 31,963.6% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 14,679,377 shares of the medical equipment provider’s stock worth $31,000 after acquiring an additional 14,633,595 shares during the last quarter. BlackRock Inc. increased its stake in shares of Intuitive Surgical by 1.2% in the 1st quarter. BlackRock Inc. now owns 8,424,675 shares of the medical equipment provider’s stock worth $4,806,951,000 after acquiring an additional 96,860 shares during the last quarter. Vanguard Group Inc increased its stake in shares of Intuitive Surgical by 0.4% in the 3rd quarter. Vanguard Group Inc now owns 8,313,421 shares of the medical equipment provider’s stock worth $4,771,903,000 after acquiring an additional 29,260 shares during the last quarter. FMR LLC increased its stake in shares of Intuitive Surgical by 7.3% in the 1st quarter. FMR LLC now owns 6,807,862 shares of the medical equipment provider’s stock worth $3,884,429,000 after acquiring an additional 462,957 shares during the last quarter. Finally, Jennison Associates LLC increased its stake in shares of Intuitive Surgical by 37.4% in the 1st quarter. Jennison Associates LLC now owns 2,679,394 shares of the medical equipment provider’s stock worth $1,528,809,000 after acquiring an additional 729,710 shares during the last quarter. Institutional investors own 85.53% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Further Reading: What is a capital gain?

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.